MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy
Open accessAbstract
BACKGROUND: The authors are interested in identifying molecular markers that can aid in the diagnosis of adrenocortical carcinoma (ACC). The aim of this study was to identify microRNAs (miRNAs or miRs) that are differentially expressed in malignant adrenocortical tumors as compared with benign tumors and assess their potential as diagnostic predictors. METHODS: Differentially expressed miRNAs were identified using microarray profiling of adrenocortical tumors and validated by quantitative real-time RT-PCR. RESULTS: Microarray profiling in benign and primary malignant adrenocortical tumors revealed several significant differences between these histological groups. By using directed quantitative RT-PCR analysis on a subset of these differentially expressed miRNAs, the authors determined that miRs -100, -125b, and -195 were significantly down-regulated, whereas miR-483-5p was significantly up-regulated in malignant as compared with benign tumors. Furthermore, the current study shows that miR-483-5p expression can accurately categorize tumors as benign or malignant. CONCLUSIONS: The authors identified 4 miRNAs that are dysregulated in adrenocortical carcinoma. The high expression of one of these, miR-483-5p, appears to be a defining characteristic of adrenocortical malignancies, and can thus be used to accurately distinguish between benign and malignant adrenocortical tumors.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
miR-483 is located in an intron of IGF2.
“Moreover, miR-483 is located in an intron of IGF2.”
From Adrenocortical carcinoma (2014) · cites this paper as [200]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · see citing works
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R., Carey, V., Bates, D., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 13,133 · see citing works
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829 · see citing works
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969 · see citing works
Andersen, C. L., Jensen, J. L., & Ørntoft, T. F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0496 · Cited by 7,127 · see citing works
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 5,910 · see citing works
limma: Linear Models for Microarray Data
Smyth, G. K. (2005) · Statistics for Biology and Health · doi:10.1007/0-387-29362-0_23 · Cited by 5,796 · see citing works
Yang, Y., Dudoit, S., Luu, P., Lin, D., Peng, V., Ngai, J., & Speed, T. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.4.e15 · Cited by 3,722 · see citing works
Normalization of cDNA microarray data
Smyth, G. K., & Speed, T. (2003) · Methods · doi:10.1016/s1046-2023(03)00155-5 · Cited by 1,871 · see citing works
Parental imprinting of the mouse insulin-like growth factor II gene
DeChiara, T. M., Robertson, E. J., & Efstratiadis, A. (1991) · Cell · doi:10.1016/0092-8674(91)90513-x · Cited by 1,795 · see citing works
Garzon, R., Calin, G. A., & Croce, C. M. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.59.053006.104707 · Cited by 1,791 · see citing works
Icard, P., Goudet, P., Charpenay, C., Andreassian, B., Carnaille, B., Chapuis, Y., Cougard, P., Henry, J., & Proye, C. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0047-y · Cited by 543 · see citing works
Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling
Giordano, T. J., Kuick, R., Else, T., Gauger, P. G., Vinco, M., Bauersfeld, J., Sanders, D., Thomas, D. G., Doherty, G., & Hammer, G. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1067 · Cited by 401 · see citing works
Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis
Giordano, T. J., Thomas, D. G., Kuick, R., Lizyness, M., Misek, D. E., Smith, A. L., Sanders, D., Aljundi, R. T., Gauger, P. G., Thompson, N. W., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63846-1 · Cited by 383 · see citing works
de Reyniès, A., Assié, G., Rickman, D. S., Tissier, F., Groussin, L., René-Corail, F., Dousset, B., Bertagna, X., Clauser, E., & Bertherat, J. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.5678 · Cited by 382 · see citing works
Teng, X., Zhu, Y., Xiong, Y., Ge, Y.-Y., Yun, J., & Zhuang, S. (2009) · Hepatology · doi:10.1002/hep.22919 · Cited by 373 · see citing works
miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer
Soon, P. S. H., Tacon, L. J., Gill, A. J., Bambach, C. P., Sywak, M. S., Campbell, P. R., Yeh, M. W., Wong, S. G., Clifton-Bligh, R. J., Robinson, B. G., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1587 · Cited by 262 · see citing works
de Fraipont, F., El Atifi, M., Cherradi, N., Le Moigne, G., Defaye, G., Houlgatte, R., Bertherat, J., Bertagna, X., Plouin, P.-F., Baudin, E., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1075 · Cited by 261 · see citing works
The Weiss system for evaluating adrenocortical neoplasms: 25 years later
Lau, S. K., & Weiss, L. M. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.03.010 · Cited by 223 · see citing works
Doghman, M., Wakil, A. E., Cardinaud, B., Thomas, E., Wang, J., Zhao, W., Peralta-Del Valle, M. H. C., Figueiredo, B. C., Zambetti, G. P., & Lalli, E. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3970 · Cited by 221 · see citing works
Oncogenic Role of <i>miR-483-3p</i> at the <i>IGF2/483</i> Locus
Veronese, A., Lupini, L., Consiglio, J., Visone, R., Ferracin, M., Fornari, F., Zanesi, N., Alder, H., D'Elia, G., Gramantieri, L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4456 · Cited by 210 · see citing works
Kjellman, M., Kallioniemi, O., Karhu, R., Höög, A., Farnebo, L. ‐., Auer, G., Larsson, C., & Bäckdahl, M. (1996) · PubMed · Cited by 190 · see citing works
Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma
Barlaskar, F. M., Spalding, A. C., Heaton, J. H., Kuick, R., Kim, A. C., Thomas, D. G., Giordano, T. J., Ben-Josef, E., & Hammer, G. D. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1456 · Cited by 189 · see citing works
Almeida, M. Q., Fragoso, M. C. B. V., Lotfi, C. F. P., Santos, M. G., Nishi, M. Y., Costa, M. H. S., Lerario, A. M., Maciel, C. C., Mattos, G. E., Jorge, A. A. L., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0065 · Cited by 176 · see citing works
Significance of Plk1 regulation by miR‐100 in human nasopharyngeal cancer
Shi, W., Alajez, N. M., Bastianutto, C., Hui, A. B., Mocanu, J. D., Ito, E., Busson, P., Lo, K. W., Ng, R., Waldron, J. N., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24880 · Cited by 150 · see citing works
Comparative Genomic Hybridization Analysis of Adrenocortical Tumors
Sidhu, S. B., Marsh, D. J., Theodosopoulos, G., Philips, J. N., Bambach, C. P., Campbell, P. R., Magarey, C. J., Russell, C. F. J., Schulte, K., Röher, H. D., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8697 · Cited by 144 · see citing works
Brunt, L. M., & Moley, J. F. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0029-0 · Cited by 137 · see citing works
Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy
Velázquez‐Fernández, D., Laurell, C., Geli, J., Höög, A., Odeberg, J., Kjellman, M., Lundeberg, J., Hamberger, B., Nilsson, P., & Bäckdahl, M. (2005) · Surgery · doi:10.1016/j.surg.2005.09.031 · Cited by 135 · see citing works
Soon, P., Gill, A. J., Benn, D. E., Clarkson, A., Robinson, B. G., McDonald, K. L., & Sidhu, S. B. (2009) · Endocrine Related Cancer · doi:10.1677/erc-08-0237 · Cited by 135 · see citing works
Identification of Biomarkers of Adrenocortical Carcinoma Using Genomewide Gene Expression Profiling
Fernandez-Ranvier, G. G. (2008) · Archives of Surgery · doi:10.1001/archsurg.143.9.841 · Cited by 114 · see citing works
Analysis by cDNA microarrays of gene expression patterns of human adrenocortical tumors
Slater, E. P., Diehl, S. M., Langer, P., Samans, B., Ramaswamy, A., Zielke, A., & Bartsch, D. K. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02116 · Cited by 113 · see citing works
Analysis of Genomic Alterations in Sporadic Adrenocortical Lesions
Zhao, J., Speel, E. M., Muletta-Feurer, S., Rütimann, K., Saremaslani, P., Roth, J., Heitz, P. U., & Komminoth, P. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65205-4 · Cited by 104 · see citing works
MicroRNAs as biomarkers and therapeutic drugs in human cancer
Osaki, M., Takeshita, F., & Ochiya, T. (2008) · Biomarkers · doi:10.1080/13547500802646572 · Cited by 101 · see citing works
Meyer-Rochow, G. Y., Jackson, N., Conaglen, J. V., Whittle, D., Kunnimalaiyaan, M., Chen, H., Westin, G., Sandgren, J., Stalberg, P. L. H., Khanafshar, E., et al. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0142 · Cited by 86 · see citing works
Self-citationAdrenocortical carcinoma survival rates correlated to genomic copy number variants
Stephan, E. A., Chung, T., Grant, C. S., Kim, S., Hoff, D. D. V., Trent, J. M., & Demeure, M. J. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0267 · Cited by 80 · see citing works
Iliopoulos, D., Bimpaki, E. I., Nesterova, M., & Stratakis, C. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0155 · Cited by 75 · see citing works
Soon, P. S. H., Libé, R., Benn, D. E., Gill, A. J., Shaw, J., Sywak, M. S., Groussin, L., BERTAGNA, X. Y., Gicquel, C., Bertherat, J. Y., et al. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e318153ff55 · Cited by 48 · see citing works
Adrenocortical carcinoma. Our experience.
Favia, G., Lumachi, F., Carraro, P., & D'Amico, D. F. (1995) · PubMed · Cited by 24 · see citing works
Wajchenberg (2000) · doi:10.1002/(sici)1097-0142(20000215)88:4
Flagged first, then by citations
1 of the 40 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Else, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1029 · Cited by 892 · see citing works
Integrated genomic characterization of adrenocortical carcinoma
Assié, G., Letouzé, E., Fassnacht, M., Jouinot, A., Luscap, W., Barreau, O., Omeiri, H., Rodriguez, S., Perlemoine, K., René-Corail, F., et al. (2014) · Nature Genetics · doi:10.1038/ng.2953 · Cited by 732 · see citing works
MicroRNA Therapeutics in Cancer: Current Advances and Challenges
Sayed, S. R. E., Cristante, J., Guyon, L., Denis, J., Chabre, O., & Cherradi, N. (2021) · Cancers · doi:10.3390/cancers13112680 · Cited by 211 · see citing works
The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma
Özata, D. M., Caramuta, S., Velázquez‐Fernández, D., Akçakaya, P., Xie, H. Y., Höög, A., Zedenius, J., Bäckdahl, M., Larsson, C., & Lui, W. (2011) · Endocrine Related Cancer · doi:10.1530/erc-11-0082 · Cited by 191 · see citing works
Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients
Chabre, O., Libé, R., Assié, G., Barreau, O., Bertherat, J. Y., BERTAGNA, X. Y., Feige, J., & Cherradi, N. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0051 · Cited by 189 · see citing works
Characterization of microRNA expression profiles in normal and osteoarthritic human chondrocytes
Díaz‐Prado, S., Cicione, C., Muiños‐López, E., Hermida‐Gómez, T., Oreiro, N., Fernández-López, C., & Blanco, F. J. (2012) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-13-144 · Cited by 182 · see citing works
The Rectal Cancer microRNAome – microRNA Expression in Rectal Cancer and Matched Normal Mucosa
Gaedcke, J., Grade, M., Camps, J., Søkilde, R., Kaczkowski, B., Schetter, A. J., Difilippantonio, M. J., Harris, C. C., Ghadimi, Β. M., Møller, S., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0016 · Cited by 179 · see citing works
Heaton, J. H., Wood, M. A., Kim, A. C., Lima, L. O., Barlaskar, F. M., Almeida, M. Q., Fragoso, M. C. B. V., Kuick, R., Lerario, A. M., Simon, D. P., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.05.026 · Cited by 173 · see citing works
miR-483-5p Promotes Invasion and Metastasis of Lung Adenocarcinoma by Targeting RhoGDI1 and ALCAM
Song, Q., Xu, Y., Yang, C., Chen, Z., Jia, C., Chen, J., Zhang, Y., Lai, P., Fan, X., Zhou, X., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2193 · Cited by 157 · see citing works
Liu, M., Roth, A., Yu, M., Morris, R. T., Bersani, F., Rivera, M. N., Lü, J., Shioda, T., Vasudevan, S., Ramaswamy, S., et al. (2013) · Genes & Development · doi:10.1101/gad.224170.113 · Cited by 146 · see citing works
LIU, Z., Jiang, Z., Huang, J., Huang, S., Li, Y., YU, S., Yu, S., & LIU, X. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2322 · Cited by 140 · see citing works
Rechache, N. S., Wang, Y., Stevenson, H. S., Killian, J. K., Edelman, D. C., Merino, M. J., Zhang, L., Nilubol, N., Stratakis, C. A., Meltzer, P. S., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3298 · Cited by 123 · see citing works
Self-citationGenetics and epigenetics of adrenocortical tumors
Lerário, A. M., Moraitis, A. G., & Hammer, G. D. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.10.028 · Cited by 112 · see citing works
Warnecke‐Eberz, U., Chon, S., Hölscher, A. H., Drebber, U., & Bollschweiler, E. (2015) · Tumor Biology · doi:10.1007/s13277-015-3112-0 · Cited by 107 · see citing works
Analysis of circulating microRNAs in adrenocortical tumors
Szabó, D. R., Luconi, M., Szabó, P. M., Tóth, M., Szücs, N., Horányi, J., Nagy, Z., Mannelli, M., Patócs, A., Rácz, K., et al. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.148 · Cited by 102 · see citing works
Shen, J., Wang, A., Wang, Q., Gurvich, I., Siegel, A. B., Remotti, H. E., & Santella, R. M. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0237 · Cited by 100 · see citing works
De‐Ugarte, L., Yoskovitz, G., Balcells, S., Güerri‐Fernández, R., Martínez‐Díaz, S., Mellibovsky, L., Urreizti, R., Nogués, X., Grinberg, D., García‐Giralt, N., et al. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0149-2 · Cited by 94 · see citing works
Duregon, E., Volante, M., Giorcelli, J., Terzolo, M., Lalli, E., & Papotti, M. G. (2012) · Human Pathology · doi:10.1016/j.humpath.2012.07.025 · Cited by 90 · see citing works
MiR‐483–5p suppresses the proliferation of glioma cells via directly targeting ERK1
Wang, L., Shi, M., Hou, S., Ding, B., Liu, L., Ji, X., Zhang, J., & Deng, Y. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.03.035 · Cited by 77 · see citing works
MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors
Patel, D., Boufraqech, M., Jain, M., Zhang, L., He, M., Gesuwan, K., Gulati, N., Nilubol, N., Fojo, T., & Kebebew, E. (2013) · Surgery · doi:10.1016/j.surg.2013.06.022 · Cited by 86 · see citing works
Self-citationClokie, S. J. H., Lau, P., Kim, H. H., Coon, S. L., & Klein, D. C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.356733 · Cited by 84 · see citing works
Small regulatory RNAs controlled by genomic imprinting and their contribution to human disease
Girardot, M., Cavaillé, J., & Feil, R. (2012) · Epigenetics · doi:10.4161/epi.22884 · Cited by 85 · see citing works
Genetics of tumors of the adrenal cortex
Bonnet-Serrano, F., & Bertherat, J. (2018) · Endocrine Related Cancer · doi:10.1530/erc-17-0361 · Cited by 80 · see citing works
microRNAs as Potential Biomarkers in Adrenocortical Cancer: Progress and Challenges
Cherradi, N. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00195 · Cited by 77 · see citing works
Identification of cell-free microRNAs in the urine of patients with prostate cancer
Korzeniewski, N., Tosev, G., Pahernik, S. A., Hadaschik, B. A., Hohenfellner, M., & Duensing, S. M. (2014) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2014.09.015 · Cited by 70 · see citing works
Cui, Z., Cao, W., Li, J., Song, X., Mao, L., & Chen, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063887 · Cited by 70 · see citing works
Laudanski, P., Charkiewicz, R., Kuzmicki, M., Szamatowicz, J., Charkiewicz, A., & Niklinski, J. (2013) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-11-78 · Cited by 70 · see citing works
Role of microRNAs in endocrine cancer metastasis
Lima, C. R., Gomes, C. C., & dos Santos, M. F. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.03.015 · Cited by 69 · see citing works
Adrenocortical carcinoma: Past, present, and future
LaFemina, J., & Brennan, M. F. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23112 · Cited by 67 · see citing works
The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma
Patterson, E., Webb, R., Weisbrod, A. B., Bian, B., He, M., Zhang, L., Holloway, A. K., Krishna, R., Nilubol, N., Pacák, K., et al. (2012) · Endocrine Related Cancer · doi:10.1530/erc-11-0308 · Cited by 66 · see citing works
Self-citationClinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma
Caramuta, S., Lee, L., Özata, D. M., Akçakaya, P., Xie, H. Y., Höög, A., Zedenius, J., Bäckdahl, M., Larsson, C., & Lui, W. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0098 · Cited by 64 · see citing works
Neuroendocrine tumours: cracking the epigenetic code
Karpathakis, A., Dibra, H. K., & Thirlwell, C. (2013) · Endocrine Related Cancer · doi:10.1530/erc-12-0338 · Cited by 61 · see citing works
Perge, P., Butz, H., Pezzani, R., Bancos, I., Nagy, Z., Pálóczi, K., Nyírő, G., Decmann, Á., Pap, E., Luconi, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05777-0 · Cited by 62 · see citing works
Jouinot, A., & Bertherat, J. Y. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0027 · Cited by 61 · see citing works
Future directions in the diagnosis and medical treatment of adrenocortical carcinoma
Creemers, S. G., Hofland, L. J., Korpershoek, E., Franssen, G. J. H., van Kemenade, F. J., de Herder, W. W., & Feelders, R. A. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0452 · Cited by 59 · see citing works
Agosta, C., Laugier, J., Guyon, L., Denis, J., Bertherat, J. Y., Libé, R., Boisson, B., Stürm, N., Feige, J., Chabre, O., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31363 · Cited by 58 · see citing works
Duregon, E., Rapa, I., Votta, A., Giorcelli, J., Daffara, F., Terzolo, M., Scagliotti, G. V., Volante, M., & Papotti, M. G. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.04.005 · Cited by 58 · see citing works
Chronic Inflammation and Immunologic-Based Constraints in Malignant Disease
Lowe, D. B., & Storkus, W. J. (2011) · Immunotherapy · doi:10.2217/imt.11.113 · Cited by 57 · see citing works
Pardo, M., Cheng, Y., Sitbon, Y. H., Lowell, J. A., Grieco, S. F., Worthen, R. J., Desse, S. I., & Barreda-Diaz, A. (2018) · Neuroscience Research · doi:10.1016/j.neures.2018.10.012 · Cited by 57 · see citing works
Zhu, H., Dong, Q., Sheng, Y., Wei, J., Wang, G., Zhou, H.-J., Ren, N., Jia, H., Ye, Q., & Qin, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052393 · Cited by 56 · see citing works
Wang, C., Sun, Y., Wu, H., Zhao, D., & Chen, J. (2013) · Histopathology · doi:10.1111/his.12283 · Cited by 55 · see citing works
Zhou, Y., & Hong, L. (2013) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2012.0518 · Cited by 55 · see citing works
MicroRNAs in adrenal tumors: relevance for pathogenesis, diagnosis, and therapy
Igaz, P., Igaz, I., Nagy, Z., Nyírő, G., Szabó, P. M., Falus, A., Patócs, A., & Rácz, K. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1752-7 · Cited by 54 · see citing works
ENDOCRINE TUMOURS: The genomics of adrenocortical tumors
Faillot, S., & Assié, G. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1118 · Cited by 54 · see citing works
The 'omics' of adrenocortical tumours for personalized medicine
Assié, G., Jouinot, A., & Bertherat, J. Y. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.272 · Cited by 51 · see citing works
Lowery, A., Walsh, S. M., McDermott, E. W. M., & Prichard, R. S. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-0410 · Cited by 51 · see citing works
Profiling Plasma MicroRNA in Nasopharyngeal Carcinoma with Deep Sequencing
Wang, H., Yan, L., Shao, Q., Fu, S., Zhang, Z.-C., Ye, W., Zeng, Y.-X., & Shao, J. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2013.214213 · Cited by 50 · see citing works
Pathobiology and genetics of adrenocortical carcinoma
Pittaway, J. F. H., & Guasti, L. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0122 · Cited by 49 · see citing works
Loop-miRs: active microRNAs generated from single-stranded loop regions
Winter, J. J., Link, S., Witzigmann, D., Hildenbrand, C., Previti, C., & Diederichs, S. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt251 · Cited by 46 · see citing works
Current management options for recurrent adrenocortical carcinoma
Sidhu, S. B., Glover, A. R., Ip, Zhao, J., Soon, & Robinson (2013) · OncoTargets and Therapy · doi:10.2147/ott.s34956 · Cited by 46 · see citing works
Next-generation sequencing reveals microRNA markers of adrenocortical tumors malignancy
Koperski, Ł., Kotlarek, M., Świerniak, M., Kolanowska, M., Kubiak, A., Górnicka, B., Jażdżewski, K., & Wójcicka, A. (2017) · Oncotarget · doi:10.18632/oncotarget.16788 · Cited by 47 · see citing works
Feinmesser, M., Benbassat, C. A., Meiri, E., Benjamin, H., Lebanony, D., Lebenthal, Y., de Vries, L., Drozd, T., & Spector, Y. (2014) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000117 · Cited by 46 · see citing works
The Glucose-Regulated MiR-483-3p Influences Key Signaling Pathways in Cancer
Pepe, F., Visone, R., & Veronese, A. (2018) · Cancers · doi:10.3390/cancers10060181 · Cited by 44 · see citing works
Current Status and Future Targeted Therapy in Adrenocortical Cancer
Alyateem, G., & Nilubol, N. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.613248 · Cited by 42 · see citing works
Translational applications of microRNAs in cancer, and therapeutic implications
Kwok, G., Zhao, J., Weiss, J., Amaro-Mugridge, N. B., Brahmbhatt, H. N., MacDiarmid, J. A., Robinson, B. G., & Sidhu, S. B. (2017) · Non-coding RNA Research · doi:10.1016/j.ncrna.2017.12.002 · Cited by 43 · see citing works
Mizdrak, M., Kurir, T. T., & Božić, J. (2021) · Biomedicines · doi:10.3390/biomedicines9020174 · Cited by 44 · see citing works
Castro, M. A., Corrales, E. P., Molina‐Cerrillo, J., & Alonso‐Gordoa, T. (2021) · Biomedicines · doi:10.3390/biomedicines9030304 · Cited by 43 · see citing works
The Genetics of Adrenocortical Tumors
Espiard, S., & Bertherat, J. Y. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.004 · Cited by 42 · see citing works
Noncoding RNAs in Endocrine Malignancy
Kentwell, J., Gundara, J. S., & Sidhu, S. B. (2014) · The Oncologist · doi:10.1634/theoncologist.2013-0458 · Cited by 41 · see citing works
Procyanidins Modulate MicroRNA Expression in Pancreatic Islets
Castell‐Auví, A., Cedó, L., Movassat, J., Portha, B., Sánchez‐Cabo, F., Pallarès, V., Blay, M., Pinent, M., & Ardèvol, A. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf303972f · Cited by 41 · see citing works
Ronchi, C. L., Leich, E., Sbiera, S., Weismann, D., Rosenwald, A., Allolio, B., & Faßnacht, M. (2012) · Neoplasia · doi:10.1593/neo.111758 · Cited by 40 · see citing works
Zheng, X., Cui, C., Ruan, H.-L., Xue, W., Zhang, S.-D., Hu, Y., Zhou, X., & Jia, W.-H. (2014) · 癌症：英文版 · doi:10.5732/cjc.013.10246 · Cited by 39 · see citing works
MicroRNA Expression Profile in Penile Cancer Revealed by Next-Generation Small RNA Sequencing
Zhang, L., Wei, P., Shen, X., Zhang, Y., Xu, B., Zhou, J., Fan, S., Hao, Z., Shi, H., Zhang, X., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131336 · Cited by 39 · see citing works
Assumpção, M. B., Moreira, F. C., Hamoy, I. G., de Magalhães, L. L., Vidal, A. F., Pereira, A. L., Burbano, R. M. R., Khayat, A. S., Silva, A., dos Santos, S. E. B., et al. (2015) · Bioinformatics and Biology Insights · doi:10.4137/bbi.s24066 · Cited by 37 · see citing works
Dysregulation of microRNAs in adrenocortical tumors
Singh, P., Soon, P. S. H., Feige, J., Chabre, O., Zhao, J., Cherradi, N., Lalli, E., & Sidhu, S. B. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.041 · Cited by 35 · see citing works
Gara, S. K., Wang, Y., Patel, D., Liu‐Chittenden, Y., Jain, M., Boufraqech, M., Zhang, L., Meltzer, P. S., & Kebebew, E. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv908 · Cited by 34 · see citing works
Self-citationWang, C.-C., & Chen, X. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00667 · Cited by 34 · see citing works
New insights in the clinical and translational relevance of miR483-5p in adrenocortical cancer
Salvianti, F., Canu, L., Poli, G., Armignacco, R., Scatena, C., Cantini, G., Franco, A. D., Gelmini, S., Ercolino, T., Pazzagli, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19118 · Cited by 33 · see citing works
MicroRNA Expression Profiling in Adrenal Myelolipoma
Decmann, Á., Perge, P., Nyírő, G., Darvasi, O., Likó, I., Borka, K., Micsík, T., Tóth, Z., Bancos, I., Pezzani, R., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00817 · Cited by 34 · see citing works
El‐Dakroury, W. A., Midan, H. M., Abulsoud, A. I., Elshaer, S. S., El-Husseiny, A. A., Fathi, D., Abdelmaksoud, N. M., Mageed, S. S. A., Elballal, M. S., Zaki, M. B., et al. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154665 · Cited by 31 · see citing works
Advances in translational research of the rare cancer type adrenocortical carcinoma
Ghosh, C., Hu, J., & Kebebew, E. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00623-0 · Cited by 34 · see citing works
Self-citationZhang, Y. Q., Hu, J., Wang, H., Cui, J., Gao, S., Hoffman, A. R., & Li, W. (2016) · Oncotarget · doi:10.18632/oncotarget.10918 · Cited by 31 · see citing works
How to Differentiate Benign from Malignant Adrenocortical Tumors?
Viëtor, C. L., Creemers, S. G., van Kemenade, F. J., van Ginhoven, T. M., Hofland, L. J., & Feelders, R. A. (2021) · Cancers · doi:10.3390/cancers13174383 · Cited by 33 · see citing works
The human adrenal cortex: growth control and disorders
Lotfi, C. F. P., Kremer, J. L., Passaia, B. D. S., & Cavalcante, I. P. (2018) · Clinics · doi:10.6061/clinics/2018/e473s · Cited by 30 · see citing works
MicroRNAs in endocrine tumors.
Butz, H., & Patócs, A. (2019) · PubMed Central · Cited by 28 · see citing works
Hiramatsu, N., Chiang, K., Aivati, C., Rodvold, J. J., Lee, J.-M., Han, J., Chea, L., Zanetti, M., Koo, E. H., & Lin, J. H. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008336 · Cited by 27 · see citing works
Medical Approaches in Adrenocortical Carcinoma
Paragliola, R. M., Corsello, A., Locantore, P., Papi, G., Pontecorvi, A., & Corsello, S. M. (2020) · Biomedicines · doi:10.3390/biomedicines8120551 · Cited by 29 · see citing works
Expression of LIN 28 and its regulatory micro RNA s in adult adrenocortical cancer
Faria, A. M., Sbiera, S., Ribeiro, T. C., Soares, I. C., Mariani, B. M. P., Freire, D. S., de Sousa, G. R. V., Lerário, A. M., Ronchi, C. L., Deutschbein, T., et al. (2014) · Clinical Endocrinology · doi:10.1111/cen.12607 · Cited by 28 · see citing works
The next generation of therapies for adrenocortical cancers
Kirschner, L. S. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.04.001 · Cited by 27 · see citing works
Non-Coding RNAs in Adrenocortical Cancer: From Pathogenesis to Diagnosis
Decmann, Á., Perge, P., Turai, P. I., Patócs, A., & Igaz, P. (2020) · Cancers · doi:10.3390/cancers12020461 · Cited by 27 · see citing works
Serum miR-483-5p as a potential biomarker to detect hepatocellular carcinoma
Zhang, Z., Ge, S., Wang, X., Yuan, Q., Yan, Q., Ye, H., Che, Y., Lin, Y., Zhang, J., & Liu, P. (2012) · Hepatology International · doi:10.1007/s12072-012-9341-z · Cited by 27 · see citing works
Drug resistance-related microRNAs in esophageal cancer
Hong, L., Han, Y., Lu, Q., Zhang, H., Zhao, Q., Wu, K., & Fan, D. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.711309 · Cited by 25 · see citing works
The role of microRNAs in the pathophysiology of adrenal tumors
Hassan, N., Zhao, J., & Sidhu, S. B. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.12.011 · Cited by 24 · see citing works
Xu, R., Li, J., Wei, B., Huo, W., & Wang, L. (2017) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.243.41 · Cited by 23 · see citing works
The role of epithelial growth factors and insulin growth factors in the adrenal neoplasms
Angelousi, A. G., Kyriakopoulos, G., Ansari, N. N., Karageorgou, M., & Kassi, E. N. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.05.52 · Cited by 23 · see citing works
miR-375 inhibits the proliferation and invasion of glioblastoma by regulating Wnt5a
Li, G. F., Cheng, Y. Y., Li, B. J., Zhang, C., Zhang, X., Su, J., Wang, C., Chang, L., Zhang, D., Tan, C. L., et al. (2019) · Neoplasma · doi:10.4149/neo_2018_180714n484 · Cited by 22 · see citing works
MicroRNA-205 suppresses the growth of adrenocortical carcinoma SW-13 cells via targeting Bcl-2
Wu, Y., Wang, W., Wei-lie, H., Wen-qing, X., XIAO, G., NIE, Q., Ouyang, K., & Chen, D. (2015) · Oncology Reports · doi:10.3892/or.2015.4295 · Cited by 22 · see citing works
MicroRNA-210 May Be a Preoperative Biomarker of Malignant Pheochromocytomas and Paragangliomas
Ruff, S. M., Ayabe, R. I., Malekzadeh, P., Good, M. L., Wach, M. M., Gonzales, M. K., Tirosh, A., Nilubol, N., Pacák, K., Kebebew, E., et al. (2019) · Journal of Surgical Research · doi:10.1016/j.jss.2019.04.086 · Cited by 22 · see citing works
Self-citationIp, J. C. Y., Pang, T., Glover, A. R., Soon, P. S. H., Zhao, J., Clarke, S. J., Robinson, B. G., Gill, A. J., & Sidhu, S. B. (2015) · The Oncologist · doi:10.1634/theoncologist.2014-0392 · Cited by 21 · see citing works
Jung, S., Nagy, Z., Faßnacht, M., Zambetti, G. P., Weiß, M., Reincke, M., Igaz, P., Beuschlein, F., & Hantel, C. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0249 · Cited by 21 · see citing works
Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis
Armignacco, R., Cantini, G., Canu, L., Poli, G., Ercolino, T., Mannelli, M., & Luconi, M. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0775-y · Cited by 21 · see citing works
Clinical and molecular prognostic factors in adrenocortical carcinoma
Libé, R. (2018) · Minerva Endocrinology · doi:10.23736/s0391-1977.18.02900-0 · Cited by 21 · see citing works
Early Postoperative Circulating miR-483-5p Is a Prognosis Marker for Adrenocortical Cancer
Oreglia, M., Sbiera, S., Faßnacht, M., Guyon, L., Denis, J., Cristante, J., Chabre, O., & Cherradi, N. (2020) · Cancers · doi:10.3390/cancers12030724 · Cited by 21 · see citing works
Igf2-derived intronic miR-483 promotes mouse hepatocellular carcinoma cell proliferation
Ma, N., Li, F., Li, D., Hui, Y., Wang, X., Qiao, Y., Zhang, Y., Xiang, Y., Zhou, J., Zhou, L., et al. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1121-x · Cited by 20 · see citing works
Minireview: MIRomics in Endocrinology: A Novel Approach for Modeling Endocrine Diseases
Szabó, P. M., Butz, H., Igaz, P., Rácz, K., Hunyady, L., & Patócs, A. (2013) · Molecular Endocrinology · doi:10.1210/me.2012-1220 · Cited by 21 · see citing works
Emerging Therapy for Adrenocortical Carcinoma
Aufforth, R., & Nilubol, N. (2014) · International Journal of Endocrine Oncology · doi:10.2217/ije.14.13 · Cited by 20 · see citing works
Key MicroRNA’s and Their Targetome in Adrenocortical Cancer
Chehade, M., Bullock, M., Glover, A. R., Hutvágner, G., & Sidhu, S. B. (2020) · Cancers · doi:10.3390/cancers12082198 · Cited by 19 · see citing works
mRNA and microRNA expression patterns in adrenocortical cancer.
Zsippai, A., Szabó, D. R., Szabó, P. M., Tömböl, Z., Bendes, M. R., Nagy, Z., Rácz, K., & Igaz, P. (2011) · PubMed Central · Cited by 19 · see citing works
Molecular markers of adrenocortical tumors
Jain, M., Rechache, N. S., & Kebebew, E. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23119 · Cited by 17 · see citing works
Self-citationTurai, P. I., Herold, Z., Nyírő, G., Borka, K., Micsík, T., Tõke, J., Szücs, N., Tóth, M., Patócs, A., & Igaz, P. (2022) · Cancers · doi:10.3390/cancers14040895 · Cited by 18 · see citing works
- Authors
- Patterson, E. E., Holloway, A. K., Weng, J., Fojo, T., & Kebebew, E.
- Affiliations
- National Institutes of Health (US)
- Gladstone Institutes (US)
- University of California, San Francisco (US)
- Corresponding author
- Kebebew, Electron
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2010-11-08
- Volume
- 117
- Issue
- 8
- Pages
- 1630-1639
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- PMC
- PMC3051015
- OpenAlex
- W1989143788
- Cited by
- 171
- References
- 40
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 3 · 2022: 6 · 2021: 14 · 2020: 8 · 2019: 8 · 2018: 14 · 2017: 10 · 2016: 12 · 2015: 20 · 2014: 19 · 2013: 23 · 2012: 22
- FWCI
- 17.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (Z99 CA999999)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Keywords
- adrenocortical carcinoma, adrenocortical tumors, miRNA expression profiling, miR-483-5p, miR-100, miR-125b, miR-195, tumor malignancy markers, benign versus malignant differentiation, diagnostic biomarkers
- MeSH terms
- Adrenal Cortex Neoplasms, Insulin-Like Growth Factor II, Reverse Transcriptase Polymerase Chain Reaction, Gene Expression Profiling, MicroRNAs, Eukaryotic Initiation Factor-3, Validation Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
